Clinical Trial Details
Back to clinical trials
Phase N/AAncillary or Correlative
EU3075-15: Novel Diagnostic Tests for Renal Cell Carcinoma
Protocol: IRB00085068
Overview
Primary Objective:
- To determine the sensitivity, specificity, positive predictive value, negative predictive value and accuracy of two complimentary diagnostic tests for renal cell carcinoma that have been developed at Emory in the PI and co-investigators labs.
Investigators
JP
John Petros
Location
Winship Cancer Institute
